Natus Medical Price to Earnings Ratio Trend

Natus Medical Incorporated -- USA Stock  

USD 31.20  0.50  1.63%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Price to Earnings Ratio of Natus Medical Incorporated with missing and latest data points interpolated. An alternative to [PE] representing the ratio between Adjusted Share Price and Earnings per Basic Share USD.
View

67.16 times

            10 Years Trend  
Increasing
Slightly volatile
 Price to Earnings Ratio 
      Timeline 

Natus Medical Price to Earnings Ratio Over Time

2016-12-31  26.57 
2017-12-31  26.57 
2018-12-31  67.16 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  31.40
Geometric Mean  32.25
Coefficient Of Variation  89.75
Mean Deviation  18.67
Median  32.98
Standard Deviation  28.18
Sample Variance  794.08
Range  110.03
R Value  0.37
Mean Square Error  749.13
R Squared  0.14
Significance  0.22
Slope  2.66
Total Sum of Squares  9,529

Currently Trending

V   
 NYQ 
Sold over 20 shares of
a day ago ago
Traded for 121.85
S   
 NYQ 
Purchased over 500 shares of
a day ago ago
Traded for 5.39
F   
 NYQ 
Purchased over 200 shares of
a day ago ago
Traded for 10.61